Revolutionary Diabetes Drug Outperforms Metformin in Reducing Fat and Sugar
Researchers at Kumamoto University have developed HPH-15, a new compound that outperforms metformin in managing Type 2 diabetes by effectively reducing blood glucose and fat accumulation. HPH-15 activates AMPK at lower doses, decreases subcutaneous fat, and has antifibrotic properties, offering a safer profile with reduced lactic acidosis risk. This breakthrough could revolutionize diabetes treatment by addressing both glucose control and obesity-related complications.